header image
HomeResearch-Based ProgramsCo-occurring Disorders Program

Relevant articles

These citations represent the twenty-five most relevant research articles related to the development of the Hazelden Co-occurring Disorders Program. Some of these citations link to the abstracts or full articles on the publishing journal's website.

Brown, R. A., & Ramsey, S. E. (2000). Addressing comorbid depressive symptomatology in alcohol treatment. Professional Psychology: Research and Practice, 31(4), 418-422.

Cacciola, J. S., Alterman, A. I., McKay, J. R., & Rutherford, M. J. (2001). Psychiatric comorbidity in patients with substance use disorders: Do not forget Axis II disorders. Psychiatric Annals, 31(5), 321-331.

Clark, H. W., Power, A. K., Le Fauve, C. E., & Lopez, E. I. (2008). Policy and practice implications of epidemiological surveys on co-occurring mental and substance use disorders. Journal of Substance Abuse Treatment, 34(1), 3-13.

DiClemente, C. C., Nidecker, M., & Bellack, A. S. (2008). Motivation and the stages of change among individuals with severe mental illness and substance abuse disorders. Journal of Substance Abuse Treatment, 34(1), 25-35.

Drake, R. E., Mueser, K. T., & Brunette, M. F. (2007). Management of persons with cooccurring severe mental illness and substance use disorder: Program implications. World Psychiatry, 6, 131-136.

Drake, R. E., O'Neal, E. L., & Wallach, M. A. (2008). A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. Journal of Substance Abuse Treatment, 34(1), 123-138.

Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton,W., et al. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61(8), 807-816.

Harris, K. M., & Edlund, M. J. (2005). Use of mental health care and substance abuse treatment among adults with co-occurring disorders. Psychiatric Services, 56(8), 954-959.

Hien, D. A., Cohen, L. R., Miele, G. M., Litt, L. C., & Capstick, C. (2004). Promising treatments for women with comorbid PTSD and substance use disorders. American Journal of Psychiatry, 161, 1426-1432.

Kessler, R. C., Chiu,W. T., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 617-627.

Kushner, M. G., Abrams, K., & Borchardt, C. The relationship between anxiety disorders and alcohol use disorders: A review of major perspectives and findings. (2000). Clinical Psychology Review 20(2), 149-171.

Linehan, M. M., Schmidt, H., Dimeff, L. A., Craft, J. C., Kanter, J., & Comtois, K. A. (1999). Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. American Journal on Addictions, 8(4), 279-292.

McGovern, M. P., Matzkin, A. L., & Giard, J. L. (2007). Assessing the dual diagnosis capability of addiction treatment services: The Dual Diagnosis Capability in Addiction Treatment Services (DDCAT) Index. Journal of Dual Diagnosis, 3(2), 111-123.

McGovern, M. P., Wrisley, B. R., & Drake, R. E. (2005). Special section on relapse prevention: Relapse of substance use disorder and its prevention among persons with co-occurring disorders. Psychiatric Services, 56(10), 1270-1273.

McGovern, M. P., Xie, H., Acquilano, S., Segal, S. R., Siembab, L., & Drake, R. E. (2007). Addiction treatment services and co-occurring disorders: The ASAM-PPC-2R taxonomy of program dual diagnosis capability. Journal of Addictive Diseases, 26(3), 27-37.

McGovern, M. P., Xie, H., Segal, S. R., Siembab, L., & Drake, R. E. (2006). Addiction treatment services and co-occurring disorders: Prevalence estimates, treatment practices, and barriers. Journal of Substance Abuse Treatment, 31(3), 267-275.

McLellan, A. T., Luborsky, L.,Woody, G. E., O'Brien, C. P., & Druley, K. A. (1983). Predicting response to alcohol and drug abuse treatments: Role of psychiatric severity. Archives of General Psychiatry, 40(6), 620-625.

Minkoff, K., Zweben, J., Rosenthal, R., & Ries, R. (2003). Development of service intensity criteria and program categories for individuals with co-occurring disorders. Journal of Addictive Diseases, 22(Supplement 1), 113-129.

Mueser, K. T., & Fox, L. (2002). A family intervention program for dual disorders. Community Mental Health Journal, 38(3), 253-270.

Nunes, E. V., & Levin, F. R. (2004). Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis. Journal of the American Medical Association, 291(15), 1887-1896.

Petrakis, I. L., Poling, J., Levinson, C., Nich, C., Carroll, K., Rounsaville, B., & the VA New England VISN I MIRECC Study Group. (2005). Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Biological Psychiatry, 57(10), 1128-1137.

Randall, C. L., Thomas, S. E., & Thevos, A. K. (2001). Concurrent alcoholism and social anxiety disorder: A first step toward developing effective treatments. Alcoholism: Clinical and Experimental Research, 25(2), 210-220.

Sacks, S., Banks, S., McKendrick, K., & Sacks, J. Y. (2008). Modified therapeutic community for co-occurring disorders: A summary of four studies. Journal of Substance Abuse Treatment, 34(1), 112-122.

Watkins, K. E., Hunter, S. B., Burnam, M. A., Pincus, H. A., & Nicholson, G. (2005). Review of treatment recommendations for persons with a co-occurring affective or anxiety disorder and substance use disorder. Psychiatric Services, 56(8), 913-926.

Weiss, R. D., Griffin, M. L., Kolodziej, M. E., Greenfield, S. F., Najavits, L. M., Daley, D. C., et al. (2007). A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. American Journal of Psychiatry, 164(1), 100-107.

 
Contact Our Sales Staff

Our National Outreach Sales Representatives are ready to help you.

They are knowledgeable in Hazelden products and well-versed in the needs of behavioral health professionals and their clients.

An effective, integrated
treatment program

CDP

The Co-occurring Disorders Program is the first comprehensive treatment program for people with non-severe mental health disorders that co-occur with substance use disorders. Learn more

Seven key components

The Hazelden Co-occurring Disorders Program consists of five curricula, a DVD, and the Clinical Administrator's Guidebook.

Find out more about each component, including prices and how to purchase:

Order Online

Preview CDP

Sampler and overview
Download the first chapters and sample pages from each manual

Slideshow overview
Download a presentation describing the research, background and materials that make up the program

© 2016 Hazelden Foundation
Privacy Policy Terms and Conditions Contact Us Affiliates